We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
–
AUM
$824M
AUM Growth
+$76.9M
Cap. Flow
+$17.5M
Cap. Flow %
2.13%
Top 10 Hldgs %
39.13%
Holding
290
New
24
Increased
130
Reduced
83
Closed
8

Top Buys

Rank Stock Value
1
STE icon
Steris
STE
+$3.62M
2
PPG icon
PPG Industries
PPG
+$1.92M
3
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$1.12M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$1.07M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$996K

Top Sells

Rank Stock Value
1
VO icon
Vanguard Mid-Cap ETF
VO
+$1.36M
2
MSFT icon
Microsoft
MSFT
+$1.29M
3
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$949K
4
CELG
Celgene Corp
CELG
+$765K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$662K

Sector Composition

Rank Sector Weight
1 Financials 11.12%
2 Technology 9.62%
3 Healthcare 6.56%
4 Consumer Staples 4.58%
5 Industrials 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLI icon
276
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
$200K 0.02%
+2,450
New +$196K
RGS icon
277
Regis Corp
RGS
$69.9M
$179K 0.02%
500
– –
CMT icon
278
Core Molding Technologies
CMT
$210M
$163K 0.02%
+50,000
New +$222K
MOD icon
279
Modine Manufacturing
MOD
$12.8B
$150K 0.02%
19,460
– –
FPL
280
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$127K 0.02%
13,559
– –
SNGX icon
281
Soligenix
SNGX
$5.5M
$18K ﹤0.01%
52
– –
CTHR
282
DELISTED
Charles & Colvard Ltd
CTHR
$14K ﹤0.01%
1,000
– –
ET icon
283
Energy Transfer Partners
ET
$70.1B
– –
-10,495
Closed -$138K
GM icon
284
General Motors
GM
$74.7B
– –
-6,882
Closed -$258K
HIFS icon
285
Hingham Institution for Saving
HIFS
$614M
– –
-1,350
Closed -$255K
OXY icon
286
Occidental Petroleum
OXY
$57B
– –
-6,260
Closed -$278K
STZ icon
287
Constellation Brands
STZ
$22.2B
– –
-1,015
Closed -$210K
TDG icon
288
TransDigm Group
TDG
$69.2B
– –
-421
Closed -$219K
XWEL icon
289
XWELL
XWEL
$8.87M
– –
-952
Closed -$82K
CELG
290
DELISTED
Celgene Corp
CELG
– –
-7,706
Closed -$765K
8 9 10 11
12

Similar funds

HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

Clearstead Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Clearstead Advisors held 290 positions worth $824M, up 10% from $747M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Clearstead Advisors's Q4 2019 filing shows 24 new, 130 increased, 83 reduced and 8 closed positions. Its largest new stake was Steris: 24,729 shares worth $3.77M. The largest sale was Vanguard Mid-Cap ETF, an estimated $1.36M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • Clearstead Advisors's largest Q4 2019 buy was Steris: 24,729 shares worth $3.77M.
  • Clearstead Advisors added most to PPG Industries in Q4 2019, an estimated $1.92M increase.
  • Clearstead Advisors's biggest Q4 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $1.36M.
  • Clearstead Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $765K.
  • Clearstead Advisors's ten largest holdings make up 39% of its $824M portfolio in Q4 2019.
  • Clearstead Advisors opened 24 new positions and closed 8 in Q4 2019.
  • Clearstead Advisors's portfolio value rose 10% quarter-over-quarter to $824M.

Based on Clearstead Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.